“Ahead of the anticipated emergency use authorization (EUA) of Pfizer-BioNTech’s COVID-19 vaccine for children 5–11 years old, White House officials have announced a vaccination plan that represents a departure from the approach the country took with adults. That is because it relies more heavily on physicians, clinics and pharmacies instead of mass-vaccination sites. Physicians will also be enlisted to help work with parents to get children vaccinated. The Pfizer-BioNTech vaccine for 5–11-year-olds will have a new product configuration, new national drug code (NDC), and will come with smaller vials and needles than those for adults and adolescents.”
Click on the link below to get insight on the full article.
By: Sara Berg, MS